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What is the diagnosis, and what further laboratory tests are indicated? 
DISCUSSION
Lichen planus is a T-lymphocyte-mediated disease that affects both the skin and mucous membranes (1) . Typically, skin lesions are pruritic, purple, polygonal, flat-topped papules that preferentially involve the flexor surfaces (especially the wrist) and trunk and only rarely involve the face (2) . Close examination of a papule with a magnifying lens reveals a network of gray streaks (Wickham's striae). Rare variants of lichen planus include lesions that are hypertrophic (on the shins), bullous (on the oral mucosa), and ulcerative or erosive (on the oral mucosa, palms, and soles). The isomorphic response, or Koebner's phenomenon, is characterized by the production of lesions at areas of trauma (i.e., scratches, bites, surgical sites, and healed lesions of herpes zoster) and occurs commonly in lichen planus. Koebner's phenomenon is a helpful clinical clue because it is found in only a few dermatological diseases ( Table 1 ). Resolution of lesions may result in hyper-or hypopigmentation, frequently persisting for months to years.
Mucous membranes are involved in two thirds of patients with skin lesions and may be the sole area of involvement. The inside cheeks (buccal mucosa) characteristically have silverwhite, pin-sized papules in a lacelike distribution. Lesions may also occur on the lips, palate, and tongue and less commonly on the vaginal mucous membranes. Rarely, oral lichen planus may ulcerate, producing chronic, painful erosions of the gums and mucosa. Long-standing mucosal lichen planus, especially oral ulcerative lichen planus, has been associated with carcinoma (3, 4) . On the glans penis, minute, flat, polygonal papules may be arranged in rings.
Nail changes are seen in 5% to 10% of patients (2) . Pterygium formation is distinctive in lichen planus (Figure 3 ). Other nail changes include longitudinal grooving, ridging, and splitting and a peculiar midline fissure. Proximal onycholysis (loosening) may occur with lichen planus.
Scalp lesions are seen infrequently. When present they may produce a scarring alopecia (2) . Follicular lichen planus (lichen planopilaris) is characterized by spiny erythematous follicular papules in the scalp that result in a scarring alopecia. Scalp le- Very rarely, lichen planus has been described in the esophagus and the rest of the gastrointestinal tract.
Skin biopsy specimens reveal a "saw-tooth" epidermal hyperplasia and a lichenoid interface infiltrate with vacuolar alteration along the basement membrane. Necrotic keratinocytes are present along the basal layer of the epidermis and in the dermis (Civatte bodies). Biopsy specimens of drug-induced lichen planus may have a considerable number of eosinophils. Direct immunofluorescence reveals subepidermal clumps of immunoglobulin (Ig) M (less often IgG, IgA, or C3), which correspond to the Civatte bodies (2) .
Numerous diseases have been associated with lichen planus (Table 2) . Most recently the association with hepatitis, particularly hepatitis C, has been stressed in the literature (5, 6) . Thus, all patients with a clinical or histological diagnosis of lichen planus should be evaluated with this in mind. In addition, medications have been associated with lichen planus-type drug eruptions (Table 3 ) (7). Treatment is primarily required for symptomatic patients (i.e., those with pruritus or pain from ulcers) or patients with generalized lichen planus. Corticosteroids (topical, intralesional, and systemic) are the mainstay of therapy. Retinoids (topical and systemic) (8) (9) (10) (11) , dapsone (12), cyclophosphamide (13), cyclosporine (14-16), metronidazole, hydroxychloroquine (17) , tacrolimus (18) , thalidomide (19) , and phototherapy have also been helpful. The recent introduction of topical tacrolimus has been valuable for patients with intractable mouth involvement (18) .
